Genpact Recognized as a Leader in Life Sciences Regulatory and Medical Affairs in 2024 Everest Group PEAK Matrix® Assessment
Genpact (NYSE: G) has been recognized as a Leader in the Everest Group Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® assessment for 2024. This ranking highlights Genpact's outstanding global delivery and AI capabilities, including advanced digital solutions across the regulatory and medical affairs value chain.
Key factors contributing to Genpact's leadership position include:
- Comprehensive suite of digital solutions
- Strategic partnerships with companies like AWS and Veeva
- Cutting-edge AI capabilities, such as Health Agency Q&A and Marketing Authorization Supply Transfer
- Strong presence in the medical technology space
- Expertise in key opinion leader engagement and medical science liaison support
The recognition underscores Genpact's commitment to delivering innovative AI solutions supported by deep industry expertise to clients worldwide in the complex global regulatory environment.
Genpact (NYSE: G) è stata riconosciuta come un Leader nella valutazione PEAK Matrix® dell'Everest Group per le Operazioni Regolatorie e di Affari Medici nelle Scienze della Vita per il 2024. Questa classificazione mette in evidenza le eccezionali capacità di consegna globale e di intelligenza artificiale di Genpact, inclusi soluzioni digitali avanzate lungo la catena del valore regolatorio e degli affari medici.
I fattori chiave che contribuiscono alla posizione di leadership di Genpact includono:
- Un'ampia gamma di soluzioni digitali
- Partnership strategiche con aziende come AWS e Veeva
- Capacità di intelligenza artificiale all'avanguardia, come il Q&A per le Agenzie Sanitarie e il Trasferimento di Fornitura per l'Autorizzazione al Mercato
- Presenza significativa nel settore della tecnologia medica
- Esperienza nel coinvolgimento di leader di opinione e supporto alla liaison scientifica medica
Questo riconoscimento sottolinea l'impegno di Genpact a fornire soluzioni innovative di intelligenza artificiale supportate da una profonda esperienza nel settore ai clienti in tutto il mondo, in un complesso ambiente regolatorio globale.
Genpact (NYSE: G) ha sido reconocida como un Líder en la evaluación PEAK Matrix® del Everest Group para las Operaciones Regulatorias y de Asuntos Médicos en Ciencias de la Vida para 2024. Esta clasificación destaca las excepcionales capacidades de entrega global e inteligencia artificial de Genpact, incluyendo soluciones digitales avanzadas a lo largo de la cadena de valor regulatoria y de asuntos médicos.
Los factores clave que contribuyen a la posición de liderazgo de Genpact incluyen:
- Una completa suite de soluciones digitales
- Asociaciones estratégicas con empresas como AWS y Veeva
- Capacidades de inteligencia artificial de vanguardia, como Preguntas y Respuestas para Agencias de Salud y Transferencia de Suministro de Autorización de Marketing
- Fuerte presencia en el espacio de tecnología médica
- Experiencia en el compromiso con líderes de opinión clave y apoyo a enlaces de ciencia médica
El reconocimiento subraya el compromiso de Genpact para ofrecer soluciones innovadoras de inteligencia artificial respaldadas por una profunda experiencia en la industria a clientes de todo el mundo en el complejo entorno regulatorio global.
Genpact (NYSE: G)는 2024년 에버레스트 그룹 생명과학 규제 및 의료 업무 운영 PEAK Matrix® 평가에서 리더로 인정받았습니다. 이 등급은 규제 및 의료 업무 가치 사슬 전반에 걸친 탁월한 글로벌 전달 및 AI 능력을 강조합니다.
Genpact의 리더십 위치에 기여하는 주요 요인은 다음과 같습니다:
- 종합적인 디지털 솔루션 제품군
- AWS와 Veeva와 같은 회사와의 전략적 파트너십
- 건강 기관 Q&A 및 마케팅 승인 공급 이전과 같은 최첨단 AI 능력
- 의료 기술 분야에서의 강력한 존재감
- 주요 의견 리더와의 협력 및 의료 과학 연락 지원 전문성
이번 인정은 복잡한 글로벌 규제 환경에서 전 세계 고객에게 깊은 산업 전문성에 기반한 혁신적인 AI 솔루션을 제공하겠다는 Genpact의 헌신을 강조합니다.
Genpact (NYSE: G) a été reconnue comme un Leader dans l'évaluation PEAK Matrix® du Everest Group pour les opérations réglementaires et médicales dans les sciences de la vie pour 2024. Ce classement souligne les capacités d’exécution mondiale et d'IA exceptionnelles de Genpact, y compris des solutions numériques avancées sur toute la chaîne de valeur des affaires réglementaires et médicales.
Les facteurs clés qui contribuent à la position de leader de Genpact comprennent :
- Une suite complète de solutions numériques
- Partenariats stratégiques avec des entreprises telles qu'AWS et Veeva
- Capacités d'IA à la pointe, telles que les Q&A pour les agences sanitaires et le transfert d'autorisation de marché
- Une forte présence dans le domaine des technologies médicales
- Expertise dans l'engagement des leaders d'opinion clés et le soutien aux relations de sciences médicales
Cette reconnaissance souligne l'engagement de Genpact à fournir des solutions IA innovantes soutenues par une expertise sectorielle approfondie à ses clients dans le monde entier, dans un environnement réglementaire mondial complexe.
Genpact (NYSE: G) wurde als Leader im PEAK Matrix®-Bewertungsverfahren der Everest Group für regulatorische und medizinische Angelegenheiten in den Life Sciences für 2024 anerkannt. Dieses Ranking hebt die herausragenden globalen Lieferfähigkeiten und KI-Kompetenzen von Genpact hervor, einschließlich fortschrittlicher digitaler Lösungen entlang der Wertschöpfungskette für regulatorische und medizinische Angelegenheiten.
Schlüsselfaktoren, die zur Führungsposition von Genpact beitragen, umfassen:
- Umfassendes Angebot digitaler Lösungen
- Strategische Partnerschaften mit Unternehmen wie AWS und Veeva
- Spitzenmäßige KI-Fähigkeiten, wie z. B. Q&A für Gesundheitsbehörden und den Transfer von Genehmigungsversorgung
- Starke Präsenz im Bereich der Medizintechnologie
- Expertise im Engagement von Meinungsführern und Unterstützung der medizinischen Wissenschaftler
Diese Anerkennung unterstreicht das Engagement von Genpact, innovative KI-Lösungen anzubieten, die auf einer tiefen Branchenerfahrung basieren, und dies weltweit in einem komplexen regulatorischen Umfeld zu tun.
- None.
- None.
Ranking highlights Genpact's outstanding global delivery and AI capabilities, including advanced digital and AI solutions across regulatory and medical affairs value chain
As stated in the Everest Group report, Genpact earned this distinction due to its comprehensive suite of digital solutions, strategic partnerships with companies such as AWS and Veeva, and cutting-edge AI capabilities. Everest Group also highlighted notable Genpact digital and AI solutions:
- Health Agency Q&A, which uses generative AI and Natural Language Processing (NLP) to automate responses to health authority inquiries, and
- Marketing Authorization Supply Transfer, which enables integrated planning and tracking of regulatory and supply milestones with built-in business algorithms and regulatory intelligence.
"In today's complex global regulatory environment, enterprises need partners to navigate regulations, drive AI innovation, and achieve speed to market, safety, and compliance," said Sanjiv Tandon, Global Business Leader, Life Sciences, Genpact. "Being recognized as a top-three leader in life sciences underscores our commitment to delivering innovative AI solutions, supported by deep industry expertise, to our clients worldwide."
The report also acknowledged Genpact's strong presence in the medical technology space, highlighting Genpact's expertise in key opinion leader engagement and medical science liaison support, both of which ensure clients receive top-tier consultation and operational support.
"Life sciences enterprises face challenges such as navigating complex compliance systems, adapting to shifting regulations, and meeting diverse regional standards," said Lloyd Fernandes, Life Sciences Practice Director, Everest Group. "As a result, there is increasing reliance on external service providers for deep expertise and advanced technology. Genpact is well-positioned to meet these needs, offering comprehensive services across regulatory affairs. Its ability to integrate deep domain expertise with robust digital solutions to automate regulatory tasks and enhance compliance processes is highly regarded by clients."
Visit here for more information about Genpact's life science solutions and services.
About Genpact
Genpact (NYSE: G) is a global professional services and solutions firm delivering outcomes that shape the future. Our 125,000+ people across 30+ countries are driven by our innate curiosity, entrepreneurial agility, and desire to create lasting value for clients. Powered by our purpose – the relentless pursuit of a world that works better for people – we serve and transform leading enterprises, including the Fortune Global 500, with our deep business and industry knowledge, digital operations services, and expertise in data, technology, and AI.
Get to know us at genpact.com and on LinkedIn, X, YouTube, and Facebook.
MEDIA CONTACT:
Sue Martenson
Genpact Media Relations
susan.martenson@genpact.com
+1 978.905.9582
View original content to download multimedia:https://www.prnewswire.com/news-releases/genpact-recognized-as-a-leader-in-life-sciences-regulatory-and-medical-affairs-in-2024-everest-group-peak-matrix-assessment-302210115.html
SOURCE Genpact Ltd.
FAQ
What recognition did Genpact (G) receive in the 2024 Everest Group PEAK Matrix® Assessment?
What key factors contributed to Genpact's (G) leadership position in the 2024 Everest Group assessment?
What specific AI solutions did Everest Group highlight for Genpact (G) in the 2024 assessment?
How does Genpact (G) address the challenges faced by life sciences enterprises according to the 2024 Everest Group report?
